1. Home
  2. DHX vs PLRX Comparison

DHX vs PLRX Comparison

Compare DHX & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DHI Group Inc.

DHX

DHI Group Inc.

HOLD

Current Price

$1.72

Market Cap

85.4M

ML Signal

HOLD

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.20

Market Cap

74.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DHX
PLRX
Founded
1991
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
85.4M
74.4M
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
DHX
PLRX
Price
$1.72
$1.20
Analyst Decision
Buy
Hold
Analyst Count
2
11
Target Price
$4.75
$3.79
AVG Volume (30 Days)
165.3K
1.0M
Earning Date
02-04-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$131,236,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.21
$1.10
52 Week High
$3.34
$12.88

Technical Indicators

Market Signals
Indicator
DHX
PLRX
Relative Strength Index (RSI) 49.98 39.73
Support Level $1.70 $1.17
Resistance Level $1.84 $1.31
Average True Range (ATR) 0.08 0.05
MACD 0.01 -0.01
Stochastic Oscillator 50.00 21.05

Price Performance

Historical Comparison
DHX
PLRX

About DHX DHI Group Inc.

DHI Group Inc is a provider of artificial intelligence-powered software products, online tools and services to deliver career marketplaces to candidates and employers globally. DHI's brands includes Dice and Clearance Jobs enable recruiters and hiring managers to efficiently search, match and connect with skilled technologists in specialized fields, particularly technology and those with active government security clearances. The company derive the majority of revenue came from the sale of recruitment packages, which allow customers to promote jobs on websites and source candidates through their resume databases. Recruitment packages are typically provided through contractual arrangements with annual, quarterly or monthly payment terms.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

Share on Social Networks: